TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/16 16:05 | 2/27/16 | EPRS | Epirus Biopharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wyand Michael | MA | O | Chief Te | M.a | 0 | 0.00 | 0 | 4 | 13 | 33 | D | -79 | -71 | -50 | -23 | -13 | 4 | 10 | -11 | 4 | -10 | -4 | -81 | ||
3/1/16 16:09 | 2/27/16 | EPRS | Epirus Biopharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wyand Michael | MA | O | Chief Te | M.d | 0 | 0.00 | 0 | 4 | 13 | 33 | D | -83 | -75 | -46 | -44 | 9 | -1 | -8 | -9 | 6 | 24 | -3 | -76 | ||
9/14/15 16:30 | 9/14/15 | EPRS | Epirus Biopharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wyand Michael | MA | O | Chief Te | M.d | 9 | 1.00 | 1 | 9 | 40 | 30 | D | -87 | -33 | -41 | 1 | -9 | 24 | 17 | 6 | 0 | 2 | -20 | -40 | -47 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |